Enzo Biochem, Inc. (ENZB)
OTCMKTS · Delayed Price · Currency is USD
0.6989
+0.0114 (1.65%)
Inactive · Last trade price on Aug 19, 2025
Enzo Biochem Income Statement
Financials in millions USD. Fiscal year is August - July.
Millions USD. Fiscal year is Aug - Jul.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 30, 2025 | Jul '24 Jul 31, 2024 | Jul '23 Jul 31, 2023 | Jul '22 Jul 31, 2022 | Jul '21 Jul 31, 2021 | Jul '20 Jul 31, 2020 |
| 27.47 | 31.91 | 31.06 | 32.64 | 117.73 | 76.02 | |
Revenue Growth (YoY) | -17.59% | 2.72% | -4.85% | -72.27% | 54.87% | -6.34% |
Cost of Revenue | 15.71 | 17.28 | 19.5 | 19.21 | 64.15 | 52.25 |
Gross Profit | 11.77 | 14.63 | 11.57 | 13.43 | 53.58 | 23.77 |
Selling, General & Admin | 20.9 | 24.36 | 32.4 | 28.52 | 49.63 | 49.69 |
Research & Development | 2.15 | 2.64 | 3.9 | 2.44 | 3.25 | 4.45 |
Operating Expenses | 23.05 | 27 | 36.3 | 30.96 | 52.89 | 54.14 |
Operating Income | -11.28 | -12.37 | -24.74 | -17.53 | 0.69 | -30.37 |
Interest Expense | -0.2 | -0.2 | -1.4 | - | - | - |
Interest & Investment Income | 2.41 | 3.54 | 0.28 | 0.18 | 0.01 | 0.45 |
Currency Exchange Gain (Loss) | 0.73 | -0.19 | 1.28 | -2.22 | 0.27 | 0.91 |
Other Non Operating Income (Expenses) | 0.49 | -0.6 | -0.44 | 0.02 | -0.01 | 0.49 |
EBT Excluding Unusual Items | -7.84 | -9.82 | -25.02 | -19.56 | 0.96 | -28.52 |
Gain (Loss) on Sale of Investments | - | - | - | -1.28 | -0.08 | - |
Legal Settlements | - | - | - | 0.5 | - | - |
Other Unusual Items | - | - | - | - | 7 | - |
Pretax Income | -7.84 | -9.82 | -25.02 | -20.34 | 7.88 | -28.52 |
Earnings From Continuing Operations | -7.84 | -9.82 | -25.02 | -20.34 | 7.88 | -28.52 |
Earnings From Discontinued Operations | -13.24 | -16.26 | 45.31 | 2.08 | - | - |
Net Income | -21.08 | -26.08 | 20.29 | -18.26 | 7.88 | -28.52 |
Net Income to Common | -21.08 | -26.08 | 20.29 | -18.26 | 7.88 | -28.52 |
Shares Outstanding (Basic) | 52 | 51 | 49 | 49 | 48 | 48 |
Shares Outstanding (Diluted) | 52 | 51 | 49 | 49 | 48 | 48 |
Shares Change (YoY) | 3.46% | 3.54% | 1.17% | 0.56% | 1.32% | 0.46% |
EPS (Basic) | -0.40 | -0.51 | 0.41 | -0.38 | 0.16 | -0.60 |
EPS (Diluted) | -0.40 | -0.51 | 0.41 | -0.38 | 0.16 | -0.60 |
Free Cash Flow | -16.35 | -26.8 | -39.74 | -20.06 | -4.05 | -19.35 |
Free Cash Flow Per Share | -0.31 | -0.53 | -0.81 | -0.41 | -0.08 | -0.41 |
Dividend Per Share | 0.100 | 0.100 | - | - | - | - |
Gross Margin | 42.83% | 45.86% | 37.24% | 41.14% | 45.51% | 31.27% |
Operating Margin | -41.06% | -38.75% | -79.64% | -53.69% | 0.59% | -39.95% |
Profit Margin | -76.73% | -81.73% | 65.32% | -55.94% | 6.69% | -37.52% |
Free Cash Flow Margin | -59.50% | -84.01% | -127.93% | -61.46% | -3.44% | -25.45% |
EBITDA | -9.93 | -11.09 | -22.05 | -14.7 | 3.35 | -27.59 |
EBITDA Margin | -36.13% | -34.77% | -71.00% | -45.03% | 2.84% | -36.29% |
D&A For EBITDA | 1.35 | 1.27 | 2.68 | 2.83 | 2.65 | 2.78 |
EBIT | -11.28 | -12.37 | -24.74 | -17.53 | 0.69 | -30.37 |
EBIT Margin | -41.06% | -38.75% | -79.64% | -53.69% | 0.59% | -39.95% |
Advertising Expenses | - | 0.13 | 0.35 | 0.58 | 0.4 | 0.44 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.